Apple paid a Masimo exec millions of dollars worth of shares – as well as doubling his salary – in order to persuade him to bring patented blood oxygen tech to the company, claims a new report today.
Today’s report is the latest episode in a long-running battle between the two companies over whether or not the Apple Watch’s pulse oximeter uses Masimo’s patented tech …
more…
